Chase AIPricingFAQs
Display currency
Loading news…

Biomunex

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Paris, Ile-de-France, France Founded 2014 1-10 employees For Profit

BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on developing therapeutics in the area of immuno-oncology.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Patents
13
2 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
Patents granted
13
Trademarks
2
Top patent class
Organic Chemistry
IT spend
$140K

Company Info

Founded
2014
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
13
HQ
Paris, Ile-de-France, France
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.1
Trend (90d)
2.5

Key People at Biomunex

President, CEO & Founder
1
professional contacts at Biomunex
Contact execs at Biomunex

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Biomunex

Loading news…

FAQs about Biomunex

People who checked this page also checked these

Browse the full Acquirezy directory.
Biomunex - Company Profile, Full Acquisitions List, Funding and Investments